Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer

9Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of systemic therapies on the prevention or management of AIMSS in patients with Stage I-III hormone receptor-positive breast cancer.

Cite

CITATION STYLE

APA

Roberts, K. E., Rickett, K., Chatfield, M. D., & Woodward, N. E. (2018, November 5). Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD013167

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free